Insulin Exerts Direct Effects on Carcinogenic Transformation of Human Endometrial Organotypic Cultures

REFERENCES

• Siegel R, Naishadham D, Jemal A. Cancer statistics. CA Cancer J Clin 2013;63(1):11–30.
   PubMed Web of Science ®Google Scholar
• Pollak M. Insulin and insulin-like growth factor signalling in neoplasia. Nat Rev Cancer 2008;8(12):915–928.
   PubMed Web of Science ®Google Scholar
• Godsland IF. Insulin resistance and hyperinsulinaemia in the development and progression of cancer. Clin Sci 2010;118(5): 315–332.
   Web of Science ®Google Scholar
• Brinton LA, Berman ML, Mortel R, Twiggs LB, Barrett RJ, Wilbanks GD, Lannom L, Hoover RN. Reproductive, menstrual, and medical risk factors for endometrial cancer: results from a case-control study. Am J Obstet Gynecol 1992;167(5): 1317–1325.
   PubMed Web of Science ®Google Scholar
• Potischman N, Hoover RN, Brinton LA, Siiteri P, Dorgan JF, Swanson CA, Berman ML, Mortel R, Twiggs LB, Barrett RJ, Wilbanks GD, Persky V, Lurain JR. Case–control study of endogenous steroid hormones and endometrial cancer. J Natl Cancer Inst 1996;88(16):1127–1135.
   PubMed Web of Science ®Google Scholar
• Berstein LM, Kvatchevskaya JO, Poroshina TE, Kovalenko IG, Tsyrlina EV, Zimarina TS, Ourmantcheeva AF, Ashrafian L, Thijssen JHH. Insulin resistance, its consequences for the clinical course of the disease, and possibilities of correction in endometrial cancer. J Cancer Res Clin Oncol 2004;130(11): 687–693.
   PubMed Web of Science ®Google Scholar
• Petridou E, Koukoulomatis P, Alexe DM, Voulgaris Z, Spanos E, Trichopoulos D. Endometrial cancer and the IGF system: a case–control study in Greece. Oncology 2003;64(4):341–345.
   PubMed Web of Science ®Google Scholar
• Nagamani, M, Stuart CA. Specific binding and growth-promoting activity of insulin in endometrial cancer cells in culture. Am J Obstet Gynecol 1998;179(1):6–12.
   PubMed Web of Science ®Google Scholar
• Cusi K, Maezono K, Osman A, Pendergrass M, Patti ME, Pratipanawatr T, DeFronzo RA, Kahn CR, Mandarino LJ. Insulin resistance differentially affects the PI 3-kinase- and MAP kinase-mediated signaling in human muscle. J Clin Invest 2000;105(3):311–320.
   PubMed Web of Science ®Google Scholar
• Alessi DR, Andjelkovic M, Caudwell B, Cron P, Morrice N, Cohen P, Hemmings BA. Mechanism of activation of protein kinase B by insulin and IGF-1. EMBO J 1996;15(23):6541–6551.
   PubMed Web of Science ®Google Scholar
• Aksamitiene E, Kiyatkin A, Kholodenko BN. Cross-talk between mitogenic Ras/MAPK and survival PI3K/Akt pathways: a fine balance. Biochem Soc Trans 2012;40(1):139–146.
   PubMedGoogle Scholar
• Belfiore A. The role of insulin receptor isoforms and hybrid insulin/IGF-I receptors in human cancer. Curr Pharm Des 2007;13(7):671–686.
   PubMed Web of Science ®Google Scholar
• McCampbell AS, Broaddus RR, Loose DS, Davies PJA. Overexpression of the insulin-like growth factor I receptor and activation of the AKT pathway in hyperplastic endometrium. Clin Cancer Res 2006;12(21):6373–6378.
   PubMed Web of Science ®Google Scholar
• Federici M, Porzio O, Zucaro L, Giovannone B, Borboni P, Marini MA, Lauro D, Sesti G. Increased abundance of insulin/IGF-I hybrid receptors in adipose tissue from NIDDM patients. Mol Cell Endocrinol 1997;135(1):41–47.
   PubMed Web of Science ®Google Scholar
• Zhang G, Li X, Zhang L, Zhao L, Jiang J, Wang J, Wei L. The expression and role of hybrid insulin/insulin-like growth factor receptor type 1 in endometrial carcinoma cells. Cancer Genet Cytogenet 2010;200(2):140–148.
   PubMed Web of Science ®Google Scholar
• Lathi RB, Hess AP, Tulac S, Nayak NR, Conti M, Giudice LC. Dose-dependent insulin regulation of insulin-like growth factor binding protein-1 in human endometrial stromal cells is mediated by distinct signaling pathways. J Clin Endocrinol Metab 2005;90(3):1599–1606.
   PubMed Web of Science ®Google Scholar
• Soft Agar Assay for Colony Formation Protocol. 2007; Available from: http://www.mnstate.edu/provost/Soft%20Agar%20Assay%20Protocol.pdf.
   Google Scholar
• Benbrook D. Organotypic cultures represent tumor microenvironment for drug testing. Drug Discov Today 2006;3:143–148.
   Google Scholar
• Kamelle S, Sienko A, Benbrook DM. Retinoids and steroids regulate menstrual phase histological features in human endometrial organotypic cultures. Fertil Steril 2002;78(3):596–602.
   PubMed Web of Science ®Google Scholar
• Luo J. Glycogen synthase kinase 3beta (GSK3beta) in tumorigenesis and cancer chemotherapy. Cancer Lett 2009;273(2):194–200.
   PubMed Web of Science ®Google Scholar
• Thornton TM, Pedraza-Alva G, Deng B, Wood CD, Aronshtam A, Clements JL, Sabio G, Davis RJ, Matthews DE, Doble B, Rincon M. Phosphorylation by p38 MAPK as an alternative pathway for GSK3beta inactivation. Science 2008;320(5876):667–670.
   PubMed Web of Science ®Google Scholar
• Guan X-B, Sun Z, Chen X-X, Wu H-R, Zhang X-Y. Inhibitory effects of Zengshengping fractions on DMBA-induced buccal pouch carcinogenesis in hamsters. Chinese Med J 2012;125(2): 332–337.
   PubMed Web of Science ®Google Scholar
• Ansari KM, Das M. Skin tumor promotion by argemone oil/alkaloid in mice: evidence for enhanced cell proliferation, ornithine decarboxylase, cyclooxygenase-2 and activation of MAPK/NF-kappaB pathway. Food Chem Toxicol 2010;48(1): 132–138.
   PubMed Web of Science ®Google Scholar
• de Assis S, Wang M, Goel S, Foxworth A, Helferich W, Hilakivi-Clarke L. Excessive weight gain during pregnancy increases carcinogen-induced mammary tumorigenesis in Sprague-Dawley and lean and obese Zucker rats. J Nutr 2006;136(4):998–1004.
   PubMed Web of Science ®Google Scholar
• Mao J-H, To MD, Perez-Losada J, Wu D, Del Rosario R, Balmain A. Mutually exclusive mutations of the Pten and ras pathways in skin tumor progression. Genes & Dev 2004;18(15):1800–1805.
   PubMed Web of Science ®Google Scholar
• Reichelt J, Furstenberger G, Magin TM. Loss of keratin 10 leads to mitogen-activated protein kinase (MAPK) activation, increased keratinocyte turnover, and decreased tumor formation in mice. J Invest Dermatol 2004;123(5):973–981.
   PubMed Web of Science ®Google Scholar
• To-Ho KW, Cheung HW, Ling MT, Wong YC, Wang X. MAD2DeltaC induces aneuploidy and promotes anchorage-independent growth in human prostate epithelial cells. Oncogene 2008;27(3):347–357.
   PubMed Web of Science ®Google Scholar
• Shoji K, Oda K, Kashiyama T, Ikeda Y, Nakagawa S, Sone K, Miyamoto Y, Hiraike H, Tanikawa M, Miyasaka A, Koso T, Matsumoto Y, Wada-Hiraike O, Kawana K, Kuramoto H, McCormick F, Aburatani H, Yano T, Kozuma S, Taketani Y. Genotype-dependent efficacy of a dual PI3K/mTOR inhibitor, NVP-BEZ235, and an mTOR inhibitor, RAD001, in endometrial carcinomas. PLoS ONE [Electronic Resource]. 2012;7(5):e37431.
   Google Scholar
• Wang L-E, Ma H, Hale KS, Yin M, Meyer LA, Liu H, Li J, Lu KH, Hennessy BT, Li X, Spitz MR, Wei Q, Mills GB. Roles of genetic variants in the PI3K and RAS/RAF pathways in susceptibility to endometrial cancer and clinical outcomes. J Cancer Res Clin Oncol 2012;138(3):377–385.
   PubMed Web of Science ®Google Scholar
• Buck E, Gokhale P, Koujak S. Compensatory insulin receptor (IR) activation on inhibition of insulin-like growth factor-1 receptor (IGF-1R): rationale for cotargeting IGF-1R and IR in cancer. Mol Cancer Ther 2010;9(10):2652–2664.
   PubMed Web of Science ®Google Scholar
• Evans JMM, Donnelly LA, Emslie-Smith AM, Alessi DR, Morris AD. Metformin and reduced risk of cancer in diabetic patients. BMJ 2005;330(7503):1304–1305.
   PubMed Web of Science ®Google Scholar
• Bowker SL, Majumdar SR, Veugelers P, Johnson JA. Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin. Diabetes Care 2006;29(2):254–258.
   PubMed Web of Science ®Google Scholar
• Cantrell LA, Zhou C, Mendivil A, Malloy KM, Gehrig PA, Bae-Ju VL. Metformin is a potent inhibitor of endometrial cancer cell proliferation–implications for a novel treatment strategy. Gynecol Oncol 2010;116(1):92–98.
   PubMed Web of Science ®Google Scholar